Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: DRonabinol Treatment of OSA [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial to evaluate dronabinol for obstructive sleep apnea is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronabinol (dronabinol)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Obstructive Sleep Apnea | Phase 1, Phase 2 | Status: RECRUITING